Literature DB >> 28142077

Associations among oxidative stress, Lp-PLA2 activity and arterial stiffness according to blood pressure status at a 3.5-year follow-up in subjects with prehypertension.

Minkyung Kim1, Hye Jin Yoo2, Minjoo Kim1, Hyeon Yeong Ahn1, Jiyeong Park2, Sang-Hyun Lee3, Jong Ho Lee4.   

Abstract

BACKGROUND AND AIMS: We aimed to determine changes in oxidative stress, lipoprotein-associated phospholipase A2 (Lp-PLA2) activity and arterial stiffness in subjects with persistent prehypertensive symptoms during a 3.5-year follow-up period.
METHODS: We divided 254 subjects with prehypertension according to their blood pressure (BP) status at 3.5 years of follow-up into three groups: reversed normotensive, persistent prehypertensive and developed hypertensive group. BP, serum lipid profile, oxidized LDL (ox-LDL), Lp-PLA2 activity and brachial-ankle pulse wave velocity (ba-PWV) were measured at baseline and the 3.5-year follow-up.
RESULTS: The reversed normotensive group showed a significant reduction in average BP (14.7/10.1 mmHg), whereas the developed hypertensive group showed a significant increase in average BP (15.2/11.5 mmHg). The persistent prehypertensive group showed increases in serum lipid profiles, circulating levels of Lp-PLA2 activity, ox-LDL and arterial stiffness as measured by ba-PWV at 3.5 years. The persistent prehypertensive and developed hypertensive groups showed greater increases in ox-LDL than the reversed normotensive group. The developed hypertensive group showed greater increases in Lp-PLA2, 8-epi-PGF2α, and ba-PWV than those observed in the reversed normotensive and persistent prehypertensive groups. In all subjects, changes (Δ) in systolic blood pressure (SBP) positively correlated with Δ Lp-PLA2, Δ ox-LDL, Δ urinary 8-epi-PGF2α and Δ ba-PWV.
CONCLUSIONS: This study indicates that in persistent prehypertension, increased ox-LDL hydrolysis by Lp-PLA2 enhances arterial stiffness without an age-related increase in BP.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Lp-PLA(2); Oxidative stress; Persistent prehypertension; ba-PWV; ox-LDL

Mesh:

Substances:

Year:  2017        PMID: 28142077     DOI: 10.1016/j.atherosclerosis.2017.01.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

Review 1.  The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation.

Authors:  Marilyn J Cipolla; David S Liebeskind; Siu-Lung Chan
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-10       Impact factor: 6.200

Review 2.  Oxidative Stress and Inflammation, Key Targets of Atherosclerotic Plaque Progression and Vulnerability: Potential Impact of Physical Activity.

Authors:  Pauline Mury; Erica N Chirico; Mathilde Mura; Antoine Millon; Emmanuelle Canet-Soulas; Vincent Pialoux
Journal:  Sports Med       Date:  2018-12       Impact factor: 11.136

Review 3.  State of the Art Review: Brachial-Ankle PWV.

Authors:  Hirofumi Tomiyama; Kazuki Shiina
Journal:  J Atheroscler Thromb       Date:  2020-05-23       Impact factor: 4.928

4.  Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients.

Authors:  Jia-Sian Hou; Chih-Hsien Wang; Yu-Hsien Lai; Chiu-Huang Kuo; Yu-Li Lin; Bang-Gee Hsu; Jen-Pi Tsai
Journal:  Nutrients       Date:  2020-07-21       Impact factor: 5.717

5.  Sympathoexcitation and impaired arterial baroreflex sensitivity are linked to vascular inflammation in individuals with elevated resting blood pressure.

Authors:  Ida T Fonkoue; Ngoc-Anh Le; Melanie L Kankam; Dana DaCosta; Toure N Jones; Paul J Marvar; Jeanie Park
Journal:  Physiol Rep       Date:  2019-04

6.  Lipoprotein-associated phospholipase A2 levels, endothelial dysfunction and arterial stiffness in patients with stable coronary artery disease.

Authors:  Konstantinos Mourouzis; Gerasimos Siasos; Evangelos Oikonomou; Marina Zaromitidou; Vicky Tsigkou; Alexis Antonopoulos; Evanthia Bletsa; Panagiota Stampouloglou; Konstantinos Vlasis; Manolis Vavuranakis; Dimitris Tousoulis
Journal:  Lipids Health Dis       Date:  2021-02-14       Impact factor: 3.876

Review 7.  Cardiovascular Outcomes in the Acute Phase of COVID-19.

Authors:  Hiroki Nakano; Kazuki Shiina; Hirofumi Tomiyama
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

Review 8.  Vascular Dysfunction and Its Cardiovascular Consequences During and After COVID-19 Infection: A Narrative Review.

Authors:  Manisha Kar
Journal:  Vasc Health Risk Manag       Date:  2022-03-05

9.  Molecular Mechanism of Resveratrol's Lipid Membrane Protection.

Authors:  Qinqin Fei; David Kent; Wesley M Botello-Smith; Fariah Nur; Saadia Nur; Abdelaziz Alsamarah; Payal Chatterjee; Maria Lambros; Yun Luo
Journal:  Sci Rep       Date:  2018-01-25       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.